Onset PrevenTIon of urinary retention in Orthopaedic Nursing and rehabilitation, OPTION-a study protocol for a randomised trial by a multi-professional facilitator team and their first-line managers' implementation strategy.

Evidence-based practice Facilitation Guideline Implementation Leadership Nursing Orthopaedic care Rehabilitation Urinary retention

Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
26 06 2021
Historique:
received: 13 04 2021
accepted: 08 06 2021
entrez: 27 6 2021
pubmed: 28 6 2021
medline: 18 11 2021
Statut: epublish

Résumé

The Onset PrevenTIon of urinary retention in Orthopaedic Nursing and rehabilitation, OPTION, project aims to progress knowledge translation vis-à-vis evidence-based bladder monitoring in orthopaedic care, to decrease the risk of urinary retention, and voiding complications. Urinary retention is common whilst in hospital for hip surgery. If not properly identified and managed, there is a high risk of complications, some lifelong and life threatening. Although evidence-based guidelines are available, the implementation is lagging. Twenty orthopaedic sites are cluster randomised into intervention and control sites, respectively. The intervention sites assemble local facilitator teams among nursing and rehabilitation staff, including first-line managers. The teams receive a 12-month support programme, including face-to-face events and on-demand components to map and bridge barriers to guideline implementation, addressing leadership behaviours and de-implementation of unproductive routines. All sites have access to the guidelines via a public healthcare resource, but the control sites have no implementation support. Baseline data collection includes structured assessments of urinary retention procedures via patient records, comprising incidence and severity of voiding issues and complications, plus interviews with managers and staff, and surveys to all hip surgery patients with interviews across all sites. Further assessments of context include the Alberta Context Tool used with staff, the 4Ps tool for preference-based patient participation used with patients, and data on economic aspects of urinary bladder care. During the implementation intervention, all events are recorded, and the facilitators keep diaries. Post intervention, the equivalent data collections will be repeated twice, and further data will include experiences of the intervention and guideline implementation. Data will be analysed with statistical analyses, including comparisons before and after, and between intervention and control sites. The qualitative data are subjected to content analysis, and mixed methods are applied to inform both clinical outcomes and the process evaluation, corresponding to a hybrid design addressing effectiveness, experiences, and outcomes. The OPTION trial has a potential to account for barriers and enablers for guideline implementation in the orthopaedic context in general and hip surgery care in particular. Further, it may progress the understanding of implementation leadership by dyads of facilitators and first-line managers. The study was registered as NCT04700969 with the U.S. National Institutes of Health Clinical Trials Registry on 8 January 2021, that is, prior to the baseline data collection.

Sections du résumé

BACKGROUND
The Onset PrevenTIon of urinary retention in Orthopaedic Nursing and rehabilitation, OPTION, project aims to progress knowledge translation vis-à-vis evidence-based bladder monitoring in orthopaedic care, to decrease the risk of urinary retention, and voiding complications. Urinary retention is common whilst in hospital for hip surgery. If not properly identified and managed, there is a high risk of complications, some lifelong and life threatening. Although evidence-based guidelines are available, the implementation is lagging.
METHODS
Twenty orthopaedic sites are cluster randomised into intervention and control sites, respectively. The intervention sites assemble local facilitator teams among nursing and rehabilitation staff, including first-line managers. The teams receive a 12-month support programme, including face-to-face events and on-demand components to map and bridge barriers to guideline implementation, addressing leadership behaviours and de-implementation of unproductive routines. All sites have access to the guidelines via a public healthcare resource, but the control sites have no implementation support. Baseline data collection includes structured assessments of urinary retention procedures via patient records, comprising incidence and severity of voiding issues and complications, plus interviews with managers and staff, and surveys to all hip surgery patients with interviews across all sites. Further assessments of context include the Alberta Context Tool used with staff, the 4Ps tool for preference-based patient participation used with patients, and data on economic aspects of urinary bladder care. During the implementation intervention, all events are recorded, and the facilitators keep diaries. Post intervention, the equivalent data collections will be repeated twice, and further data will include experiences of the intervention and guideline implementation. Data will be analysed with statistical analyses, including comparisons before and after, and between intervention and control sites. The qualitative data are subjected to content analysis, and mixed methods are applied to inform both clinical outcomes and the process evaluation, corresponding to a hybrid design addressing effectiveness, experiences, and outcomes.
DISCUSSION
The OPTION trial has a potential to account for barriers and enablers for guideline implementation in the orthopaedic context in general and hip surgery care in particular. Further, it may progress the understanding of implementation leadership by dyads of facilitators and first-line managers.
TRIAL REGISTRATION
The study was registered as NCT04700969 with the U.S. National Institutes of Health Clinical Trials Registry on 8 January 2021, that is, prior to the baseline data collection.

Identifiants

pubmed: 34174917
doi: 10.1186/s13012-021-01135-x
pii: 10.1186/s13012-021-01135-x
pmc: PMC8233619
doi:

Banques de données

ClinicalTrials.gov
['NCT04700969']

Types de publication

Clinical Trial Protocol Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

65

Références

MedGenMed. 2001 Mar 05;3(2):2
pubmed: 11549951
BMC Health Serv Res. 2018 Nov 14;18(1):857
pubmed: 30428882
JAMA. 2020 Dec 22;324(24):2489-2490
pubmed: 33351025
J Healthc Leadersh. 2017 Mar 29;9:15-23
pubmed: 29355212
Int J Evid Based Healthc. 2009 Dec;7(4):283-95
pubmed: 21631868
Can J Anaesth. 2011 Dec;58(12):1097-104
pubmed: 21989549
BMC Health Serv Res. 2009 Dec 15;9:234
pubmed: 20003531
Injury. 2018 Dec;49(12):2209-2215
pubmed: 30366830
Syst Rev. 2014 Jun 05;3:57
pubmed: 24903267
J Adv Nurs. 2008 Apr;62(1):107-15
pubmed: 18352969
Health Expect. 2015 Dec;18(6):2522-35
pubmed: 24938672
Minerva Anestesiol. 2010 Feb;76(2):120-30
pubmed: 20150853
Urol Nurs. 2003 Oct;23(5):341-6, 354
pubmed: 14621356
Implement Sci. 2012 Mar 27;7:25
pubmed: 22453077
Worldviews Evid Based Nurs. 2013 Feb;10(1):51-65
pubmed: 22647197
Implement Sci. 2018 Nov 16;13(1):138
pubmed: 30442165
Worldviews Evid Based Nurs. 2020 Jun;17(3):185-192
pubmed: 32558215
Int J Orthop Trauma Nurs. 2020 Aug;38:100779
pubmed: 32439319
Eur J Orthop Surg Traumatol. 2018 Feb;28(2):283-289
pubmed: 28900757
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
J Eval Clin Pract. 2019 Dec;25(6):1070-1073
pubmed: 30916440
J Gen Intern Med. 2010 Jan;25 Suppl 1:50-5
pubmed: 20077152
Scand J Urol Nephrol. 2012 Apr;46(2):84-90
pubmed: 22150754
J Eval Clin Pract. 2019 Apr;25(2):282-289
pubmed: 29411463
BMC Health Serv Res. 2017 Jan 7;17(1):16
pubmed: 28061856
Anesthesiology. 2009 May;110(5):1139-57
pubmed: 19352147
Nurse Educ Today. 2017 Sep;56:29-34
pubmed: 28651100
J Clin Nurs. 2017 Nov;26(21-22):3345-3353
pubmed: 27982485
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Malays Orthop J. 2020 Nov;14(3):110-113
pubmed: 33403070
BMC Health Serv Res. 2013 Feb 19;13:68
pubmed: 23421736
Worldviews Evid Based Nurs. 2016 Feb;13(1):25-31
pubmed: 26788694
Implement Sci. 2018 Nov 16;13(1):137
pubmed: 30442174
Int J Health Policy Manag. 2016 Apr 11;5(8):477-486
pubmed: 27694661
Orthopedics. 2015 Jun;38(6):e507-11
pubmed: 26091224
Scand J Caring Sci. 2016 Jun;30(2):365-73
pubmed: 26265314
Implement Sci. 2020 Aug 27;15(1):68
pubmed: 32854718
BMC Health Serv Res. 2020 Jul 29;20(1):702
pubmed: 32727451
Pilot Feasibility Stud. 2019 Aug 19;5:103
pubmed: 31452925
J Arthroplasty. 2017 Dec;32(12):3748-3751
pubmed: 28781015
J Nurs Scholarsh. 2016 May;48(3):294-302
pubmed: 27074390
J Arthroplasty. 1995 Dec;10(6):732-6
pubmed: 8749753
Implement Sci. 2018 Nov 16;13(1):141
pubmed: 30442157

Auteurs

Ann Catrine Eldh (AC)

Department of Health, Medicine and Caring Sciences, Linköping University, SE-581 83, Linköping, Sweden. ann.catrine.eldh@liu.se.
Department of Public Health and Caring Sciences, Uppsala University, Box 564, SE-751 22, Uppsala, Sweden. ann.catrine.eldh@liu.se.

Eva Joelsson-Alm (E)

Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Södersjukhuset, SE-118 83, Stockholm, Sweden.

Per Wretenberg (P)

Faculty of Health and Medicine, Department of Orthopedics, Örebro University, SE-701 82, Örebro, Sweden.

Maria Hälleberg-Nyman (M)

Faculty of Medicine and Health, School of Health Sciences, Örebro University, SE-701 82, Örebro, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH